Noninvasive diagnostic criteria for hepatocellular carcinoma in hepatic masses >2cm in a hepatitis B virus-endemic area

Liver International

Volumn 31, Issue 10, 2011, Pages 1468-1476

  Kim, Sung Eun ^a   Lee, Han Chu ^a   Shim, Ju Hyun ^a   Park, Hyun Joo ^a   Kim, Kang Mo ^a   Kim, Pyo Nyun ^a   Shin, Yong Moon ^a   Yu, Eun Sil ^a   Chung, Young Hwa ^a   Suh, Dong Jin ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

fetoprotein; Carcinoma; Hepatitis B virus; Hepatocellular; Spiral computed; Tomography

Indexed keywords

ALPHA FETOPROTEIN; IOPROMIDE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SIZE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDEMIC DISEASE; FEMALE; HEPATITIS B; HIGH RISK PATIENT; HUMAN; IMAGE ENHANCEMENT; KOREA; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

ALPHA-FETOPROTEINS; BIOPSY, FINE-NEEDLE; CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC IMAGING; HUMANS; LIVER NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80053982942     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02529.x     Document Type: Article

References (34)

1. Bruix J, Sherman M.Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
2. Bruix J, Sherman M.Management of hepatocellular carcinoma: An update. Hepatology 2011; 53: 1020-2.
3. Isonishi S, Ogura A, Kiyokawa T, et al. Alpha-fetoprotein (AFP)-producing ovarian tumor in an elderly woman. Int J Clin Oncol 2009; 14: 70-3.
4. Ishikura H, Kirimoto K, Shamoto M, et al. Hepatoid adenocarcinomas of the stomach. An analysis of seven cases. Cancer 1986; 58: 119-26.
5. Motoyama T, Aizawa K, Watanabe H, Fukase M, Saito K.Alpha-fetoprotein producing gastric carcinomas: a comparative study of three different subtypes. Acta Pathol Jpn 1993; 43: 654-61.
6. An M, Shin JA, Lee SM, et al. Liver metastasis of colon cancer with a high serum alpha-fetoprotein level: report of a case. Korean J Hepatol 2006; 12: 562-7.
7. Hocking GR, Shembrey M, Hay D, Ostor AG.Alpha-fetoprotein-producing adenocarcinoma of the sigmoid colon with possible hepatoid differentiation. Pathology 1995; 27: 277-9.
8. Kurihara K, Konishi F, Kanazawa K, Fujii T, Saito K.Alpha-fetoprotein-producing carcinoma of the colon: report of a case. Surg Today 1997; 27: 453-6.
9. Heo SH, Her KH, Kim SW, et al. Alpha-fetoprotein-producing carcinoma of the gallbladder. J Korean Surg Soc 1999; 57: 149-55.
10. Chok KS, Ng KK, Cheung TT, et al. An update on long-term outcome of curative hepatic resection for hepatocholangiocarcinoma. World J Surg 2009; 33: 1916-21.
11. Kim KH, Lee SG, Park EH, et al. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma. Ann Surg Oncol 2009; 16: 623-9.
12. Luca A, Caruso S, Milazzo M, et al. Multidetector-row computed tomography (MDCT) for the diagnosis of hepatocellular carcinoma in cirrhotic candidates for liver transplantation: prevalence of radiological vascular patterns and histological correlation with liver explants. Eur Radiol 2010; 20: 898-907.
13. Hussain SM, Terkivatan T, Zondervan PE, et al. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 2004; 24: 3-17; discussion 18-9.
14. Cho JM, Kim SH, Lee WJ, et al. Adenomatous hyperplasia of the liver: triple-phase helical CT findings. J Korean Radiol Soc 1999; 41: 945-59.
15. Tajima T, Funakoshi A, Ikeda Y, et al. Nonfunctioning adrenal rest tumor of the liver: radiologic appearance. J Comput Assist Tomogr 2001; 25: 98-101.
16. Lin CW, Lai CH, Hsu CC, et al. Primary hepatic carcinoid tumor: a case report and review of the literature. Cases J 2009; 2: 90-4.
17. Levy I, Greig PD, Gallinger S, Langer B, Sherman M.Resection of hepatocellular carcinoma without preoperative tumor biopsy. Ann Surg 2001; 234: 206-9.
18. Torzilli G, Minagawa M, Takayama T, et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999; 30: 889-93.
19. Yuen MF, Cheng CC, Lauder IJ, et al. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000; 31: 330-5.
20. Nelson RC, Chezmar JL.Diagnostic approach to hepatic hemangiomas. Radiology 1990; 176: 11-3.
21. Choi BI, Lee KH, Han JK, Lee JM.Hepatic arterioportal shunts: dynamic CT and MR features. Korean J Radiol 2002; 3: 1-15.
22. Di Lelio A, Cestari C, Lomazzi A, Beretta L.Cirrhosis: diagnosis with sonographic study of the liver surface. Radiology 1989; 172: 389-92.
23. Lencioni R, Cioni D, Della Pina C, Crocetti L, Bartolozzi C.Imaging diagnosis. Semin Liver Dis 2005; 25: 162-70.
24. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22: 983-93.
25. Befeler AS, Di Bisceglie AM.Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002; 122: 1609-19.
26. Terjung B, Lemnitzer I, Dumoulin FL, et al. Bleeding complications after percutaneous liver biopsy. An analysis of risk factors. Digestion 2003; 67: 138-45.
27. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73.
28. Trevisani F, D'Intino PE, Morselli-Labate AM, et al. Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001; 34: 570-5.
29. McGlynn KA, Tarone RE, El-Serag HB.A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev 2006; 15: 1198-203.
30. Chen TM, Huang PT, Tsai MH, et al. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy. J Gastroenterol Hepatol 2007; 22: 669-75.
31. Silver HK, Gold P, Shuster J, et al. Alpha(1)-fetoprotein in chronic liver disease. N Engl J Med 1974; 291: 506-8.
32. Benson AB III, Abrams TA, Ben-Josef E, et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw 2009; 7: 350-91.
33. Koh KC, Lee H, Choi MS, et al. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg 2005; 189: 120-5.
34. Maeda T, Adachi E, Kajiyama K, Sugimachi K, Tsuneyoshi M.Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. Hum Pathol 1995; 26: 956-64.